Figure 1.
Follow-up of 12 patients with FIP1L1-PDGFRA–positive MLN-eo after discontinuation of imatinib. CMR was assessed by nested RT-PCR.
Follow-up of 12 patients with FIP1L1-PDGFRA–positive MLN-eo after discontinuation of imatinib. CMR was assessed by nested RT-PCR.